Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Review Article

Latent Tuberculosis Infection (LTBI) and Its Potential Targets: An Investigation into Dormant Phase Pathogens

Author(s): Gopichand Gutti, Karan Arya and Sushil Kumar Singh*

Volume 19, Issue 19, 2019

Page: [1627 - 1642] Pages: 16

DOI: 10.2174/1389557519666190625165512

Price: $65

Abstract

One-third of the world’s population harbours the latent tuberculosis infection (LTBI) with a lifetime risk of reactivation. Although, the treatment of LTBI relies significantly on the first-line therapy, identification of novel drug targets and therapies are the emerging focus for researchers across the globe. The current review provides an insight into the infection, diagnostic methods and epigrammatic explanations of potential molecular targets of dormant phase bacilli. This study also includes current preclinical and clinical aspects of tubercular infections and new approaches in antitubercular drug discovery.

Keywords: Latent tuberculosis infection, diagnosis, biomarkers, molecular targets, Mtb topoisomerase-I, lysine 3-aminotransferase, isocitrate lyase, regulon.

« Previous
Graphical Abstract

[1]
Lin, M.Y.; Ottenhoff, T.H. Host-pathogen interactions in latent Mycobacterium tuberculosis infection: Identification of new targets for tuberculosis intervention. Endocr. Metab. Immune Disord. Drug Targets, 2008, 8(1), 15-29.
[2]
Sakamoto, K. The pathology of Mycobacterium tuberculosis infection. Veterin. Pathol., 2012, 49(3), 423-439.
[3]
Cardona, P.J. New insights on the nature of latent tuberculosis infection and its treatment. Inflamm. Allergy Drug Targets, 2007, 6(1), 27-39.
[4]
Lin, P.L.; Flynn, J.L. Understanding latent tuberculosis: A moving target. J. Immunol., 2010, 185(1), 15-22.
[5]
Weis, S.E.; Pogoda, J.M.; Yang, Z.; Cave, M.D.; Wallace, C.; Kelley, M.; Barnes, P.F. Transmission dynamics of tuberculosis in Tarrant county, Texas. Am. J. Respir. Crit. Care Med., 2002, 166(1), 36-42.
[6]
Barnes, P.F.; Yang, Z.; Preston-Martin, S.; Pogoda, J.M.; Jones, B.E.; Otaya, M.; Eisenach, K.D.; Knowles, L.; Harvey, S.; Cave, M.D. Patterns of tuberculosis transmission in Central Los Angeles. JAMA, 1997, 278(14), 1159-1163.
[7]
Small, P.M.; Hopewell, P.C.; Singh, S.P.; Paz, A.; Parsonnet, J.; Ruston, D.C.; Schecter, G.F.; Daley, C.L.; Schoolnik, G.K. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N. Engl. J. Med., 1994, 330(24), 1703-1709.
[8]
Jasmer, R.M.; Hahn, J.A.; Small, P.M.; Daley, C.L.; Behr, M.A.; Moss, A.R.; Creasman, J.M.; Schecter, G.F.; Paz, E.A.; Hopewell, P.C. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann. Intern. Med., 1999, 130(12), 971-978.
[9]
Millet, J-P.; Moreno, A.; Fina, L.; Del Baño, L.; Orcau, A.; De Olalla, P.G.; Cayla, J.A. Factors that influence current tuberculosis epidemiology. Eur. Spine J., 2013, 22(4), 539-548.
[10]
Selwyn, P.A.; Alcabes, P.; Hartel, D.; Buono, D.; Schoenbaum, E.E.; Klein, R.S.; Davenny, K.; Friedland, G.H. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N. Engl. J. Med., 1992, 327(24), 1697-1703.
[11]
Global Tuberculosis Report 2016. World Health Organization, 2016, 1-214. http://apps.who.int/medicinedocs/documents/s23098en/s23098en.pdf (Accessed June 07, 2017).
[12]
Tomioka, H.; Tatano, Y.; Yasumoto, K.; Shimizu, T. Recent advances in antituberculous drug development and novel drug targets. Expert Rev. Respir. Med., 2008, 2(4), 455-471.
[13]
Sellamuthu, S.; Bhat, M.; Kumar, A.; Singh, S. Phenothiazine: A better Scaffold against Tuberculosis. Mini Rev. Med. Chem., 2017, 18(17), 1442-1451.
[http://dx.doi.org/10.2174/1389557517666170220152651]
[14]
Sridevi, J.P.; Suryadevara, P.; Janupally, R.; Sridhar, J.; Soni, V.; Anantaraju, H.S.; Yogeeswari, P.; Sriram, D. Identification of potential Mycobacterium tuberculosis topoisomerase I inhibitors: A study against active, dormant and resistant tuberculosis. Eur. J. Pharm. Sci., 2015, 72(1), 81-92.
[15]
D., Joshi S.; Kumar, D.; R Dixit, S.; S Joshi, A.; M Aminabhavi, T. Drug resistance of antitubercular agents at the genetic level in mycobacterium species: A road map to drug development for counteracting the resistance. Mini Rev. Org. Chem., 2016, 13(4), 262-280.
[16]
Barry, C.E., III; Boshoff, H.I.; Dartois, V.; Dick, T.; Ehrt, S.; Flynn, J.; Schnappinger, D.; Wilkinson, R.J.; Young, D. The spectrum of latent tuberculosis: Rethinking the biology and intervention strategies. Nat. Rev. Microbiol., 2009, 7(12), 845.
[17]
Flynn, J.L.; Chan, J. Tuberculosis: Latency and reactivation. Infect. Immun., 2001, 69(7), 4195-4201.
[18]
Zambuzi, F.A.; Cardoso-Silva, P.M.; Espindola, M.S.; Soares, L.S.; Galvao-Lima, L.J.; Brauer, V.S.; Gomes, M.S.; Amaral, L.R.; Schaller, M.; Bollela, V.R.; Frantz, F.G. Identification of promising plasma immune biomarkers to differentiate active pulmonary tuberculosis. Cytokine, 2016, 88(1), 99-107.
[19]
Meintjes, G.; Skolimowska, K.H.; Wilkinson, K.A.; Matthews, K.; Tadokera, R.; Conesa-Botella, A.; Seldon, R.; Rangaka, M.X.; Rebe, K.; Pepper, D.J. Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome. Am. J. Respir. Crit. Care Med., 2012, 186(4), 369-377.
[20]
Yang, C.S. Advancing host-directed therapy for tuberculosis. Microb. Cell, 2017, 4(3), 105.
[21]
Joshi, S.D.; Kumar, D.; Dixit, S.R.; Tigadi, N.; More, U.A.; Lherbet, C.; Aminabhavi, T.M.; Yang, K.S. Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes. . Eur. J. Med. Chem., 2016, 121(1), 21-39.
[22]
Joshi, S.D.; Kumar, D.; More, U.A.; Yang, K.S.; Aminabhavi, T.M. Design and development of pyrrole carbaldehyde: an effective pharmacophore for enoyl-ACP reductase. Med. Chem. Res., 2016, 25(4), 672-689.
[23]
Joshi, S.D.; Kumar, D.; More, U.A.; Aminabhavi, T.M. Docking, CoMFA, and CoMSIA analyses of phenoxy triazole derivatives as enoyl-ACP reductase inhibitors for Escherichia coli. Med. Chem. Res., 2014, 23(11), 4932-4955.
[24]
Satheeshkumar, S.; Amer, H.A.; Hojjat Ghasemi, G.; Gopal, N.; Shushil Kumar, S. Preliminary studies on Ligand-based design and evaluation of new mycobacterial ATP synthase inhibitors. Curr. Drug Ther., 2017, 12(1), 1-18.
[25]
Koul, A.; Vranckx, L.; Dendouga, N.; Balemans, W.; Van den Wyngaert, I.; Vergauwen, K.; Göhlmann, H.W.; Willebrords, R.; Poncelet, A.; Guillemont, J. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J. Biol. Chem., 2008, 283(37), 25273-25280.
[26]
Kumar, D.; Negi, B.; Rawat, D.S. The anti-tuberculosis agents under development and the challenges ahead. Future Med. Chem., 2015, 7(15), 1981-2003.
[27]
Geiter, L. Ending neglect: The elimination of tuberculosis in the United States; National Academies Press: Washington, D.C, 2000.
[28]
World Health Organization (WHO) Global Tuberculosis Report. 2012, 1-98. http://www.who.int/tb/publications/global_report/gtbr12_main.pdf (Accessed June 11, 2017)
[29]
US Food and Drug Administration - SIRTURO Prescribing Information. 2013, 1-25. https://www.accessdata.fda.gov/drugsatfda_ docs/label/2012/204384s000lbl.pdf (Accessed June 11, 2017)
[30]
US Food and Drug Administration. NDA 204-384 Deouty Division Director Summary Review. 2013, 1-26. https://www.accessdata. fda.gov/drugsatfda_docs/nda/2012/204384Orig1s000SumR.pdf (Accessed June 11, 2017)
[31]
Esmail, H.; Barry, C.E., III; Young, D.B.; Wilkinson, R.J. The ongoing challenge of latent tuberculosis. Philos. Trans. R. Soc. Lond. B Biol. Sci., 2014, 369(1645)20130437
[32]
Organization, W.H. Global tuberculosis control: Surveillance, planning, financing. 2009, 1-216. http://apps.who.int/iris/bitstream/10665/42889/2/9241562641.pdf (Accessed June 11, 2017)
[33]
Shaw, J.B.; Wynn-Williams, N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am. Rev. Tuberc., 1954, 69(5), 724-732.
[34]
Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm. Rep., 2000, 49(RR-6), 1-51.
[35]
Herrera, V.; Perry, S.; Parsonnet, J.; Banaei, N. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin. Infect. Dis., 2011, 52(8), 1031-1037.
[36]
Lessem, E. The tuberculosis diagnostics pipeline. Pipeline Report. 2016. http://pipelinereport.org/2016/tb-diagnostics (Accessed June 15, 2017).
[37]
Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am. J. Respir. Crit. Care Med., 2000, 161(4 Pt 2), S221-S247.
[38]
Ayub, A.; Yale, S.H.; Reed, K.D.; Nasser, R.M.; Gilbert, S.R. Testing for latent tuberculosis. Clin. Med. Res., 2004, 2(3), 191-194.
[39]
Schluger, N.W. Improving the Diagnosis of Latent TB Infection: Tools for TB Elimination? Chest, 2017, 151(6), 1207-1208.
[40]
Slutkin, G.; Perez-Stable, E.J.; Hopewell, P.C. Time course and boosting of tuberculin reactions in nursing home residents. Am. Rev. Respir. Dis., 1986, 134(5), 1048-1051.
[41]
Mazurek, G.H.; LoBue, P.A.; Daley, C.L.; Bernardo, J.; Lardizabal, A.A.; Bishai, W.R.; Iademarco, M.F.; Rothel, J.S. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA, 2001, 286(14), 1740-1747.
[42]
Lalvani, A.; Pathan, A.A.; Durkan, H.; Wilkinson, K.A.; Whelan, A.; Deeks, J.J.; Reece, W.H.; Latif, M.; Pasvol, G.; Hill, A.V. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet, 2001, 357(9273), 2017-2021.
[43]
Pai, M.; Dheda, K.; Cunningham, J.; Scano, F.; O’Brien, R. T-cell assays for the diagnosis of latent tuberculosis infection: Moving the research agenda forward. Lancet Infect. Dis., 2007, 7(6), 428-438.
[44]
Du, F.; Zhang, Z.; Gao, T.; Liu, Z.; Jia, H.; Xing, A.; Du, B.; Sun, Q.; Cao, T. Diagnosis of latent tuberculosis by ELISPOT assay and tuberculin skin test. Medecine et maladies infectieuses, 2016, 46(3), 150-153.
[45]
Weiner, J.; Maertzdorf, J.; Kaufmann, S.H. The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis. Ann. N. Y. Acad. Sci., 2013, 1283, 22-29.
[46]
Berry, M.P.; Graham, C.M.; McNab, F.W.; Xu, Z.; Bloch, S.A.; Oni, T.; Wilkinson, K.A.; Banchereau, R.; Skinner, J.; Wilkinson, R.J.; Quinn, C.; Blankenship, D.; Dhawan, R.; Cush, J.J.; Mejias, A.; Ramilo, O.; Kon, O.M.; Pascual, V.; Banchereau, J.; Chaussabel, D.; O’Garra, A. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature, 2010, 466(7309), 973-977.
[47]
Jacobsen, M.; Repsilber, D.; Gutschmidt, A.; Neher, A.; Feldmann, K.; Mollenkopf, H.J.; Ziegler, A.; Kaufmann, S.H. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J. Mol. Med. (Berl.), 2007, 85(6), 613-621.
[48]
Frediani, J.K.; Jones, D.P.; Tukvadze, N.; Uppal, K.; Sanikidze, E.; Kipiani, M.; Tran, V.T.; Hebbar, G.; Walker, D.I.; Kempker, R.R.; Kurani, S.S.; Colas, R.A.; Dalli, J.; Tangpricha, V.; Serhan, C.N.; Blumberg, H.M.; Ziegler, T.R. Plasma metabolomics in human pulmonary tuberculosis disease: A pilot study. PLoS One, 2014, 9(10)e108854
[49]
Agranoff, D.; Fernandez-Reyes, D.; Papadopoulos, M.C.; Rojas, S.A.; Herbster, M.; Loosemore, A.; Tarelli, E.; Sheldon, J.; Schwenk, A.; Pollok, R.; Rayner, C.F.; Krishna, S. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet, 2006, 368(9540), 1012-1021.
[50]
Walzl, G.; Ronacher, K.; Hanekom, W.; Scriba, T.J.; Zumla, A. Immunological biomarkers of tuberculosis. Nat. Rev. Immunol., 2011, 11(5), 343-354.
[51]
Alsleben, N.; Ruhwald, M.; Russmann, H.; Marx, F.M.; Wahn, U.; Magdorf, K. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: A case-control study. Scand. J. Infect. Dis., 2012, 44(4), 256-262.
[52]
Lawn, S.D.; Myer, L.; Edwards, D.; Bekker, L.G.; Wood, R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS, 2009, 23(13), 1717-1725.
[53]
van Pinxteren, L.A.; Cassidy, J.P.; Smedegaard, B.H.; Agger, E.M.; Andersen, P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur. J. Immunol., 2000, 30(12), 3689-3698.
[54]
Diedrich, C.R.; Mattila, J.T.; Klein, E.; Janssen, C.; Phuah, J.; Sturgeon, T.J.; Montelaro, R.C.; Lin, P.L.; Flynn, J.L. Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load. PLoS One, 2010, 5(3)e9611
[55]
Serbina, N.V.; Flynn, J.L. Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect. Immun., 1999, 67(8), 3980-3988.
[56]
Wayne, L.G.; Lin, K.Y. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect. Immun., 1982, 37(3), 1042-1049.
[57]
Graham, J.E.; Clark-Curtiss, J.E. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc. Natl. Acad. Sci., 1999, 96(20), 11554-11559.
[58]
Zu Bentrup, K.H.; Miczak, A.; Swenson, D.L.; Russell, D.G. Characterization of Activity and Expression of Isocitrate Lyase in Mycobacterium avium and Mycobacterium tuberculosis. . J. Bacteriol., 1999, 181(23), 7161-7167.
[59]
Gould, T.A.; Van De Langemheen, H.; Muñoz-Elías, E.J.; McKinney, J.D.; Sacchettini, J.C. Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis. . Mol. Microbiol., 2006, 61(4), 940-947.
[60]
Smith, C.V.; Sharma, V.; Sacchettini, J.C. TB drug discovery: Addressing issues of persistence and resistance. Tuberculosis, 2004, 84(1), 45-55.
[61]
Smith, C.V.; Huang, C-c.; Miczak, A.; Russell, D.G.; Sacchettini, J.C.; zu Bentrup, K.H. Biochemical and structural studies of malate synthase from mycobacterium tuberculosis. J. Biol. Chem., 2003, 278(3), 1735-1743.
[62]
Murphy, D.J.; Brown, J.R. Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. BMC Infect. Dis., 2007, 7, 84.
[63]
Yuan, Y.; Crane, D.D.; Simpson, R.M.; Zhu, Y.Q.; Hickey, M.J.; Sherman, D.R.; Barry, C.E., III The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc. Natl. Acad. Sci. USA, 1998, 95(16), 9578-9583.
[64]
He, H.; Zahrt, T.C. Identification and characterization of a regulatory sequence recognized by Mycobacterium tuberculosis persistence regulator MprA. J. Bacteriol., 2005, 187, 202-212.
[65]
Bretl, D.J.; Bigley, T.M.; Terhune, S.S.; Zahrt, T.C. The MprB extracytoplasmic domain negatively regulates activation of the Mycobacterium tuberculosis MprAB two-component system. J. Bacteriol., 2014, 196(2), 391-406.
[66]
Weiss, L.A.; Stallings, C.L. Essential roles for Mycobacterium tuberculosis Rel beyond the production of (p) ppGpp. J. Bacteriol., 2013, 195(24), 5629-5638.
[67]
Singh, N.; Tiwari, S.; Srivastava, K.K.; Siddiqi, M.I. Identification of novel inhibitors of mycobacterium tuberculosis pkng using pharmacophore based virtual screening, docking, molecular dynamics simulation, and their biological evaluation. J. Chem. Inf. Model., 2015, 55(6), 1120-1129.
[68]
Godbole, A.A.; Ahmed, W.; Bhat, R.S.; Bradley, E.K.; Ekins, S.; Nagaraja, V. Inhibition of Mycobacterium tuberculosis topoisomerase I by m-AMSA, a eukaryotic type II topoisomerase poison. Biochem. Biophys. Res. Commun., 2014, 446(4), 916-920.
[69]
Tse-Dinh, Y.C. Targeting bacterial topoisomerases: How to counter mechanisms of resistance. Future Med. Chem., 2016, 8(10), 1085-1100.
[70]
Tse-Dinh, Y.C. Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics. Future Med. Chem., 2015, 7(4), 459-471.
[71]
Sikder, D.; Nagaraja, V. Determination of the recognition sequence of Mycobacterium smegmatis topoisomerase I on mycobacterial genomic sequences. Nucleic Acids Res., 2000, 28(8), 1830-1837.
[72]
Ahmed, W.; Menon, S.; Godbole, A.A.; Karthik, P.V.; Nagaraja, V. Conditional silencing of topoisomerase I gene of Mycobacterium tuberculosis validates its essentiality for cell survival. FEMS Microbiol. Lett., 2014, 353(2), 116-123.
[73]
Ravishankar, S.; Ambady, A.; Awasthy, D.; Mudugal, N.V.; Menasinakai, S.; Jatheendranath, S.; Guptha, S.; Sharma, S.; Balakrishnan, G.; Nandishaiah, R.; Ramachandran, V.; Eyermann, C.J.; Reck, F.; Rudrapatna, S.; Sambandamurthy, V.K.; Sharma, U.K. Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target. Tuberculosis (Edinb.), 2015, 95(5), 589-598.
[74]
Nagaraja, V.; Godbole, A.A.; Henderson, S.R.; Maxwell, A. DNA topoisomerase I and DNA gyrase as targets for TB therapy. Drug Discov. Today, 2017, 22(3), 510-518.
[75]
Godbole, A.A.; Ahmed, W.; Bhat, R.S.; Bradley, E.K.; Ekins, S.; Nagaraja, V. Targeting Mycobacterium tuberculosis topoisomerase I by small-molecule inhibitors. Antimicrob. Agents Chemother., 2015, 59(3), 1549-1557.
[76]
Hayashi, H. Pyridoxal enzymes: Mechanistic diversity and uniformity. J. Biochem., 1995, 118(3), 463-473.
[77]
Soda, K.; Misono, H. L-Lysine: Alpha-ketoglutarate aminotransferase. II. Purification, crystallization, and properties. Biochemistry, 1968, 7(11), 4110-4119.
[78]
Duan, X.; Li, Y.; Du, Q.; Huang, Q.; Guo, S.; Xu, M.; Lin, Y.; Liu, Z.; Xie, J. Mycobacterium Lysine epsilon-aminotransferase is a novel alarmone metabolism related persister gene via dysregulating the intracellular amino acid level. Sci. Rep., 2016, 6, 19695.
[79]
Peschel, A.; Sahl, H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol., 2006, 4(7), 529-536.
[80]
Gonzalez-Curiel, I.; Castañeda-Delgado, J.; Lopez-Lopez, N.; Araujo, Z.; Hernandez-Pando, R.; Gandara-Jasso, B.; Macias-Segura, N.; Enciso-Moreno, A.; Rivas-Santiago, B. Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus. Hum. Immunol., 2011, 72(8), 656-662.
[81]
Hancock, R.E.; Haney, E.F.; Gill, E.E. The immunology of host defence peptides: Beyond antimicrobial activity. Nat. Rev. Immunol., 2016, 16(5), 321-335.
[82]
Betts, J.C.; Lukey, P.T.; Robb, L.C.; McAdam, R.A.; Duncan, K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol., 2002, 43(3), 717-731.
[83]
Ackart, D.F.; Hascall-Dove, L.; Caceres, S.M.; Kirk, N.M.; Podell, B.K.; Melander, C.; Orme, I.M.; Leid, J.G.; Nick, J.A.; Basaraba, R.J. Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis. Pathog. Dis., 2014, 70(3), 359-369.
[84]
Reshma, R.S.; Jeankumar, V.U.; Kapoor, N.; Saxena, S.; Bobesh, K.A.; Vachaspathy, A.R.; Kolattukudy, P.E.; Sriram, D. Mycobacterium tuberculosis lysine-varepsilon-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors. Bioorg. Med. Chem., 2017, 25(10), 2761-2771.
[85]
Devi, P.B.; Sridevi, J.P.; Kakan, S.S.; Saxena, S.; Jeankumar, V.U.; Soni, V.; Anantaraju, H.S.; Yogeeswari, P.; Sriram, D. Discovery of novel lysine varepsilon-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis. Tuberculosis (Edinb.), 2015, 95(6), 786-794.
[86]
Tripathi, S.M.; Ramachandran, R. Overexpression, purification and crystallization of lysine epsilon-aminotransferase (Rv3290c) from Mycobacterium tuberculosis H37Rv. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun., 2006, 62(6), 572-575.
[87]
Sharma, V.; Sharma, S.; Hoener zu Bentrup, K.; McKinney, J.D.; Russell, D.G.; Jacobs, W.R., Jr; Sacchettini, J.C. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nat. Struct. Biol., 2000, 7(8), 663-668.
[88]
Munoz-Elias, E.J.; McKinney, J.D. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med., 2005, 11(6), 638-644.
[89]
Honer Zu Bentrup, K.; Miczak, A.; Swenson, D.L.; Russell, D.G. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis. J. Bacteriol., 1999, 181(23), 7161-7167.
[90]
Liu, Y.; Zhou, S.; Deng, Q.; Li, X.; Meng, J.; Guan, Y.; Li, C.; Xiao, C. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Tuberculosis (Edinb.), 2016, 97, 38-46.
[91]
Saini, D.K.; Malhotra, V.; Dey, D.; Pant, N.; Das, T.K.; Tyagi, J.S. DevR–DevS is a bona fide two-component system of Mycobacterium tuberculosis that is hypoxia-responsive in the absence of the DNA-binding domain of DevR. Microbiology, 2004, 150(4), 865-875.
[92]
Sassetti, C.M.; Rubin, E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA, 2003, 100(22), 12989-12994.
[93]
Talaat, A.M.; Lyons, R.; Howard, S.T.; Johnston, S.A. The temporal expression profile of Mycobacterium tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA, 2004, 101(13), 4602-4607.
[94]
Voskuil, M.I.; Visconti, K.C.; Schoolnik, G.K. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb.), 2004, 84(3-4), 218-227.
[95]
Hampshire, T.; Soneji, S.; Bacon, J.; James, B.W.; Hinds, J.; Laing, K.; Stabler, R.A.; Marsh, P.D.; Butcher, P.D. Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: A model for persistent organisms? Tuberculosis (Edinb.), 2004, 84(3-4), 228-238.
[96]
Rengarajan, J.; Bloom, B.R.; Rubin, E.J. Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc. Natl. Acad. Sci. USA, 2005, 102(23), 8327-8332.
[97]
Wilkinson, R.J.; Wilkinson, K.A.; De Smet, K.A.; Haslov, K.; Pasvol, G.; Singh, M.; Svarcova, I.; Ivanyi, J. Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis. Scand. J. Immunol., 1998, 48(4), 403-409.
[98]
Caccamo, N.; Barera, A.; Di Sano, C.; Meraviglia, S.; Ivanyi, J.; Hudecz, F.; Bosze, S.; Dieli, F.; Salerno, A. Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein. Clin. Exp. Immunol., 2003, 133(2), 260-266.
[99]
Geluk, A.; Lin, M.Y.; van Meijgaarden, K.E.; Leyten, E.M.; Franken, K.L.; Ottenhoff, T.H.; Klein, M.R. T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination. Infect. Immun., 2007, 75(6), 2914-2921.
[100]
Caccamo, N.; Milano, S.; Di Sano, C.; Cigna, D.; Ivanyi, J.; Krensky, A.M.; Dieli, F.; Salerno, A. Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8(+) T lymphocytes. J. Infect. Dis., 2002, 186(7), 991-998.
[101]
Leyten, E.M.; Lin, M.Y.; Franken, K.L.; Friggen, A.H.; Prins, C.; van Meijgaarden, K.E.; Voskuil, M.I.; Weldingh, K.; Andersen, P.; Schoolnik, G.K.; Arend, S.M.; Ottenhoff, T.H.; Klein, M.R. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect., 2006, 8(8), 2052-2060.
[102]
Demissie, A.; Leyten, E.M.; Abebe, M.; Wassie, L.; Aseffa, A.; Abate, G.; Fletcher, H.; Owiafe, P.; Hill, P.C.; Brookes, R.; Rook, G.; Zumla, A.; Arend, S.M.; Klein, M.; Ottenhoff, T.H.; Andersen, P.; Doherty, T.M.; Group, V.S. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin. Vaccine Immunol., 2006, 13(2), 179-186.
[103]
Sivaramakrishnan, S.; Ortiz de Montellano, P.R. The DosS-DosT/DosR Mycobacterial Sensor System. Biosensors, 2013, 3(3), 259-282.
[104]
Giffin, M.M.; Shi, L.; Gennaro, M.L.; Sohaskey, C.D. Role of alanine dehydrogenase of Mycobacterium tuberculosis during recovery from hypoxic nonreplicating persistence. PLoS One, 2016, 11(5)e0155522
[105]
Brunner, K.; Maric, S.; Reshma, R.S.; Almqvist, H.; Seashore-Ludlow, B.; Gustavsson, A-L.; Poyraz, O.m.; Yogeeswari, P.; Lundbäk, T.; Vallin, M. Inhibitors of the cysteine synthase CysM with antibacterial potency against dormant Mycobacterium tuberculosis. J. Med. Chem., 2016, 59(14), 6848-6859.
[106]
Huang, H-L.; Krieger, I.V.; Parai, M.K.; Gawandi, V.B.; Sacchettini, J.C. Mycobacterium tuberculosis malate synthase structures with fragments reveal a portal for substrate/product exchange. J. Biol. Chem., 2016, 291(53), 27421-27432.
[107]
Sellamuthu, S.; Singh, M.; Kumar, A.; Singh, S.K. Type-II NADH Dehydrogenase (NDH-2): A promising therapeutic target for antitubercular and antibacterial drug discovery. Expert Opin. Ther. Targets, 2017, 21(6), 559-570.
[108]
Salaemae, W.; Azhar, A.; Booker, G.W.; Polyak, S.W. Biotin biosynthesis in Mycobacterium tuberculosis: Physiology, Biochemistry and Molecular intervention. Protein Cell, 2011, 2(9), 691-695.
[109]
Bashiri, G.; Squire, C.J.; Moreland, N.J.; Baker, E.N. Crystal structures of F420-dependent glucose-6-phosphate dehydrogenase FGD1 involved in the activation of the anti-tuberculosis drug candidate PA-824 reveal the basis of coenzyme and substrate binding. J. Biol. Chem., 2008, 283(25), 17531-17541.
[110]
Behr, M.A.; Wilson, M.A.; Gill, W.P.; Salamon, H.; Schoolnik, G.K.; Rane, S.; Small, P.M. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science, 1999, 284(5419), 1520-1523.
[111]
Fine, P.E. Variation in protection by BCG: Implications of and for heterologous immunity. Lancet, 1995, 346(8986), 1339-1345.
[112]
Ponnighaus, J.M.; Fine, P.E.; Sterne, J.A.; Wilson, R.J.; Msosa, E.; Gruer, P.J.; Jenkins, P.A.; Lucas, S.B.; Liomba, N.G.; Bliss, L. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet, 1992, 339(8794), 636-639.
[113]
Palmer, C.E.; Long, M.W. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am. Rev. Respir. Dis., 1966, 94(4), 553-568.
[114]
Andersen, P.; Doherty, T.M. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol., 2005, 3(8), 656-662.
[115]
Fine, P.E. BCG: The challenge continues. Scand. J. Infect. Dis., 2001, 33(4), 243-245.
[116]
Turner, J.; Rhoades, E.R.; Keen, M.; Belisle, J.T.; Frank, A.A.; Orme, I.M. Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode. Infect. Immun., 2000, 68(3), 1706-1709.
[117]
Roe, V.A. Antimicrobial agents: Pharmacology and clinical application in obstetric, gynecologic, and perinatal infections. J. Obstet. Gynecol. Neonatal Nurs., 1999, 28(6), 639-648.
[118]
Veldhuyzen van Zanten, S.J.; Sherman, P.M.; Hunt, R.H. Helicobacter pylori: New developments and treatments. CMAJ, 1997, 156(11), 1565-1574.
[119]
Wayne, L.G.; Sramek, H.A. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 1994, 38(9), 2054-2058.
[120]
Mukherjee, T.; Boshoff, H. Nitroimidazoles for the treatment of TB: past, present and future. Future Med. Chem., 2011, 3(11), 1427-1454.
[121]
Barry, C.E., III; Boshoff, H.I.; Dowd, C.S. Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis. Curr. Pharm. Des., 2004, 10(26), 3239-3262.
[122]
Matsumoto, M.; Hashizume, H.; Tomishige, T.; Kawasaki, M.; Tsubouchi, H.; Sasaki, H.; Shimokawa, Y.; Komatsu, M. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS Med., 2006, 3(11)e466
[123]
Stover, C.K.; Warrener, P.; VanDevanter, D.R.; Sherman, D.R. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature, 2000, 405(6789), 962.
[124]
Iona, E.; Giannoni, F.; Pardini, M.; Brunori, L.; Orefici, G.; Fattorini, L. Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 2007, 51(4), 1537-1540.
[125]
Stover, C.K.; Warrener, P.; VanDevanter, D.R.; Sherman, D.R.; Arain, T.M.; Langhorne, M.H.; Anderson, S.W.; Towell, J.A.; Yuan, Y.; McMurray, D.N.; Kreiswirth, B.N.; Barry, C.E.; Baker, W.R. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature, 2000, 405(6789), 962-966.
[126]
Tomioka, H.; Tatano, Y.; Yasumoto, K.; Shimizu, T. Recent advances in antituberculous drug development and novel drug targets. Expert Rev. Respir. Med., 2008, 2(4), 455-471.
[127]
Hooper, D.C.; Wolfson, J.S. The fluoroquinolones: Pharmacology, clinical uses, and toxicities in humans. Antimicrob. Agents Chemother., 1985, 28(5), 716-721.
[128]
Ginsburg, A.S.; Grosset, J.H.; Bishai, W.R. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect. Dis., 2003, 3(7), 432-442.
[129]
Ji, B.; Lounis, N.; Maslo, C.; Truffot-Pernot, C.; Bonnafous, P.; Grosset, J. In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 1998, 42(8), 2066-2069.
[130]
Tomioka, H.; Sato, K.; Akaki, T.; Kajitani, H.; Kawahara, S.; Sakatani, M. Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrob. Agents Chemother., 1999, 43(12), 3001-3004.
[131]
Alvirez-Freites, E.J.; Carter, J.L.; Cynamon, M.H. In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 2002, 46(4), 1022-1025.

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version340msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[13:19:10] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[13:19:10] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[13:19:10] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (116ms)time
  • Application (224ms)time
  • 1 x Application (65.82%)
    224ms
    1 x Booting (34.17%)
    116ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    37 statements were executed, 4 of which were duplicates, 33 unique. Show only duplicated148ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('51399716','',1,1739971150,1739971150) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1739971150
      1.33msalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('51399716','/article/99212',1,1739971150,1739971150)
      180μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 51399716 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51399716) limit 1
      22.33msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 51399716
      • 1: 51399716
      • 2: 51399716
      • 3: 51399716
      • 4: 51399716
      • 5: 51399716
      • 6: 51399716
      • 7: 51399716
      • 8: 51399716
      • 9: 51399716
      • 10: 51399716
      • 11: 51399716
      • 12: 51399716
      • 13: 51399716
      • 14: 51399716
      • 15: 51399716
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=99212
      680μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 56 limit 1
      1msalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 56
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=56) and sj.journal_id!=56 group by `j`.`nid`) as `aggregate_table`
      1.15msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=56) and sj.journal_id!=56 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      890μsalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=56) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      1.57msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=56) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      1.39msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '99212'
      700μsalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 99212
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '99212'
      3.42msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 99212
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '99212' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      650μsalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 99212
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      220μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      420μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 56 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      31.68msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 56 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      19.12msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 56 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      13.65msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 99212 limit 1
      210μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 99212
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 99212 and content_type = 'article' order by status desc limit 1
      290μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid article_nid,a.title article_title,j.title journal_title from content_by_diseases cd inner join article a on a.article_id=cd.content_id inner join journal j on j.journal_id=a.journal_id where cd.pid = 295 and cd.sub_disease_id = 607 and content_id!=99212 and cd.content_type = 'article' order by rand() limit 20
      32.26msalphaeurekaselec_live_10_06_2022Article.php#769
      Backtrace
      • 11. app/Models/Article.php:769
      • 12. app/Http/Controllers/ArticleController.php:2098
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 172993 limit 1
      370μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 172993
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      270μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'MRMC' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      350μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: MRMC
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '99212' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      390μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '9414' and content_type = 'i' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      260μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2207
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '2608' and content_type = 'v' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      240μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2231
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51399716 and j.to_ip >=51399716 )) and ((j.from_date <= 1739971150 and j.to_date >= 1739971150 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2608) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51399716 and j.to_ip >=51399716 )) and ((j.from_date <= 1739971150 and j.to_date >= 1739971150 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2608) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51399716 and j.to_ip >=51399716 )) and ((j.from_date <= 1739971150 and j.to_date >= 1739971150 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2608)
      4.97msalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2272
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51399716 and j.to_ip >=51399716 )) and ((j.from_date <= 1739971150 and j.to_date >= 1739971150 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 9414) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51399716 and j.to_ip >=51399716 )) and ((j.from_date <= 1739971150 and j.to_date >= 1739971150 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 9414) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51399716 and j.to_ip >=51399716 )) and ((j.from_date <= 1739971150 and j.to_date >= 1739971150 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 9414)
      530μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2297
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51399716 and j.to_ip >=51399716 )) and ((j.from_date <= 1739971150 and j.to_date >= 1739971150 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 99212) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51399716 and j.to_ip >=51399716 )) and ((j.from_date <= 1739971150 and j.to_date >= 1739971150 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 99212) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51399716 and j.to_ip >=51399716 )) and ((j.from_date <= 1739971150 and j.to_date >= 1739971150 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 99212)
      520μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2329
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '1627' and is_uploaded = 1 and issue_id = 9414 order by cast(first_page as SIGNED) desc limit 1
      450μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 1627
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '1642' and is_uploaded = 1 and issue_id = 9414 order by cast(first_page as SIGNED) asc limit 1
      350μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 1642
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      160μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      170μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 99212 limit 1
      3.19msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 99212
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 56 and `b`.`banner_from_date` <= 1739971150 and `b`.`banner_to_date` >= 1739971150 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.1msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 56
      • 3: 1739971150
      • 4: 1739971150
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 56 and `b`.`banner_from_date` <= 1739971150 and `b`.`banner_to_date` >= 1739971150 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.03msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 56
      • 3: 1739971150
      • 4: 1739971150
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='047c50cbf66de2478ebc1de345c07fb9'
      180μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        nYwyGqqGDrj9sJWHngn6LuFuolmVE0oovHmkjaUe
        uc_cart_id
        047c50cbf66de2478ebc1de345c07fb9
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/99212" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/99212
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:8 [ "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        []
        
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Wed, 19 Feb 2025 13:19:10 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6IlQyM25UNndoc1oxaWp4NnJrV2U1bnc9PSIsInZhbHVlIjoiTlpseGQxWU1BTTZvVGZXWFpPL1NBU0VPNXZvSW1SVXI0VWlJNEo4UndhRUpzRFF0bjBFUFRHTDMwdmpCNFZBWjliS3M5Yy9lcFVkU3p0Zmd5Nll6b0RTZFFiMEtaaFFEOXNNeFoxY0FtZ1lid3VPQTk0elJFeUZJc25tM2lkcDciLCJtYWMiOiJhOWU4YjhhMjYwNDlhZTc5MDVlYmJjODcxOWViOTRhOGUzZmI1MzEwZjUxMzgwZWVkYjU4M2RlNjBmYjhjNTJmIiwidGFnIjoiIn0%3D; expires=Sat, 22 Feb 2025 01:19:10 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6IlQyM25UNndoc1oxaWp4NnJrV2U1bnc9PSIsInZhbHVlIjoiTlpseGQxWU1BTTZvVGZXWFpPL1NBU0VPNXZvSW1SVXI0VWlJNEo4UndhRUpzRFF0bjBFUFRHTDMwdmpCNFZBWjliS3M5Y" 1 => "alphaeurekaselectnet_session=eyJpdiI6InJxV2FweVZ2VDFDTXlFMSt6WVBrSVE9PSIsInZhbHVlIjoiaGJqNldEMWVSK2xITXIvcE1ORnJsaklZQ2pvSkpYNW5jVnBkeEI4RHpINWlDZnYrQ2QzalV0cEFPL0owOWtLUk13OUI4R1lzNVdFaUpZZkdFRG9MSEhkRWZaQis5MkdKaWhiN3VTVkhmcFU0N2ltNWdLZHNhY1U3VzRpQSt1NDAiLCJtYWMiOiI0OTIwNDcyMjcwOGVkMTc2N2QzNjFlMDkxMmEyN2ZmNzQ3OWMwZGViYjU0ZmFmYjA3NjhkNjJkOWY3MTg3YmEyIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6InJxV2FweVZ2VDFDTXlFMSt6WVBrSVE9PSIsInZhbHVlIjoiaGJqNldEMWVSK2xITXIvcE1ORnJsaklZQ2pvSkpYNW5jVnBkeEI4RHpINWlDZnYrQ2QzalV0cEF" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6IlQyM25UNndoc1oxaWp4NnJrV2U1bnc9PSIsInZhbHVlIjoiTlpseGQxWU1BTTZvVGZXWFpPL1NBU0VPNXZvSW1SVXI0VWlJNEo4UndhRUpzRFF0bjBFUFRHTDMwdmpCNFZBWjliS3M5Yy9lcFVkU3p0Zmd5Nll6b0RTZFFiMEtaaFFEOXNNeFoxY0FtZ1lid3VPQTk0elJFeUZJc25tM2lkcDciLCJtYWMiOiJhOWU4YjhhMjYwNDlhZTc5MDVlYmJjODcxOWViOTRhOGUzZmI1MzEwZjUxMzgwZWVkYjU4M2RlNjBmYjhjNTJmIiwidGFnIjoiIn0%3D; expires=Sat, 22-Feb-2025 01:19:10 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6IlQyM25UNndoc1oxaWp4NnJrV2U1bnc9PSIsInZhbHVlIjoiTlpseGQxWU1BTTZvVGZXWFpPL1NBU0VPNXZvSW1SVXI0VWlJNEo4UndhRUpzRFF0bjBFUFRHTDMwdmpCNFZBWjliS3M5Y" 1 => "alphaeurekaselectnet_session=eyJpdiI6InJxV2FweVZ2VDFDTXlFMSt6WVBrSVE9PSIsInZhbHVlIjoiaGJqNldEMWVSK2xITXIvcE1ORnJsaklZQ2pvSkpYNW5jVnBkeEI4RHpINWlDZnYrQ2QzalV0cEFPL0owOWtLUk13OUI4R1lzNVdFaUpZZkdFRG9MSEhkRWZaQis5MkdKaWhiN3VTVkhmcFU0N2ltNWdLZHNhY1U3VzRpQSt1NDAiLCJtYWMiOiI0OTIwNDcyMjcwOGVkMTc2N2QzNjFlMDkxMmEyN2ZmNzQ3OWMwZGViYjU0ZmFmYjA3NjhkNjJkOWY3MTg3YmEyIiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6InJxV2FweVZ2VDFDTXlFMSt6WVBrSVE9PSIsInZhbHVlIjoiaGJqNldEMWVSK2xITXIvcE1ORnJsaklZQ2pvSkpYNW5jVnBkeEI4RHpINWlDZnYrQ2QzalV0cEF" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "nYwyGqqGDrj9sJWHngn6LuFuolmVE0oovHmkjaUe" "uc_cart_id" => "047c50cbf66de2478ebc1de345c07fb9" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/99212" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-19 13:19:10GET/article/99212314371